Are BMI and Negative Hormone Receptors Prognostic Factors in HER2⁺ Early-stage Breast Cancer?

Clin Breast Cancer. 2020 Aug;20(4):359-360. doi: 10.1016/j.clbc.2020.01.010. Epub 2020 Mar 20.

Authors

Roberta Maltoni¹, Michela Palleschi², Mattia Altini², Ilaria Massa², William Balzi², Sara Ravaioli², Maria Maddalena Tumedei², Andrea Rocca², Sara Bravaccini²

Affiliations

¹ Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS, Meldola, Italy. Electronic address: roberta.maltoni@irst.emr.it.
² Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS, Meldola, Italy.

PMID: 32201162
DOI: 10.1016/j.clbc.2020.01.010

No abstract available

Publication types

Letter
Comment

MeSH terms

Body Mass Index
Breast Neoplasms*
Hormones
Humans
Prognosis
Receptor, ErbB-2
Receptors, Progesterone

Substances

Hormones
Receptors, Progesterone
Receptor, ErbB-2